Drug recall D-0456-2017

Class II Terminated reported Feb 8, 2017

Product

MIDAZOLAM INJECTION, USP, *25 mg/5 mL, (5 mg/ mL), 5 mL vials, 10 Vials per carton, Rx only, APP Pharmaceuticals, LLC Schaumburg, IL 60173 --- NDC 63323-412-05

Reason for recall

Failed Impurities/Degradation Specifications

Lots and codes

Lot 6007327, exp. 01-2017; Lot 6007329, exp. 01-2017

Recall details

Recalling firm
Fresenius Kabi USA, LLC, Lake Zurich, IL
Quantity
47, 020 vials
Distribution
Nationwide and Puerto Rico
Type
Voluntary: Firm initiated
Recall initiated
December 16, 2016
Terminated
June 22, 2018

Related products